Clincosm LogoSign in Get a demo

uterine corpus leiomyosarcoma

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York

Recruiting
  • Locally Advanced Leiomyosarcoma
  • +5 more
  • New York, New York
    Columbia University/Herbert Irving Cancer Center
Jan 4, 2023

Metastatic Leiomyosarcoma, Unresectable Leiomyosarcoma, Uterine Corpus Leiomyosarcoma Trial in Boston (Ipilimumab, Laboratory

Active, not recruiting
Has Results
  • Metastatic Leiomyosarcoma
  • +2 more
  • Ipilimumab
  • +2 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2022

Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York

Not yet recruiting
  • Locally Advanced Leiomyosarcoma
  • +8 more
  • (no location specified)
Jul 6, 2022

Recurrent Uterine Corpus Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma Trial in United States (biological,

Terminated
Has Results
  • Recurrent Uterine Corpus Sarcoma
  • +6 more
  • Bevacizumab
  • +5 more
  • Phoenix, Arizona
  • +200 more
Aug 20, 2020

Stage I Uterine Sarcoma AJCC v7, Uterine Corpus Leiomyosarcoma Trial in Worldwide (other, drug, biological)

Terminated
Has Results
  • Stage I Uterine Sarcoma AJCC v7
  • Uterine Corpus Leiomyosarcoma
  • Clinical Observation
  • +5 more
  • Huntsville, Alabama
  • +622 more
Apr 20, 2020

Stage IA Uterine Sarcoma, Stage IB Uterine Sarcoma, Stage IC Uterine Sarcoma Trial in Bronx (drug, radiation, other)

Terminated
  • Stage IA Uterine Sarcoma
  • +10 more
  • Gemcitabine Hydrochloride
  • +5 more
  • Bronx, New York
    Albert Einstein College of Medicine
Dec 10, 2019

Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma Trial in United States (Ixabepilone, Laboratory Biomarker

Completed
Has Results
  • Recurrent Uterine Corpus Sarcoma
  • Uterine Corpus Leiomyosarcoma
  • Phoenix, Arizona
  • +71 more
Aug 6, 2019

Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma Trial in Philadelphia (Thalidomide, Laboratory Biomarker

Completed
  • Recurrent Uterine Corpus Sarcoma
  • Uterine Corpus Leiomyosarcoma
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma Trial in Philadelphia (Docetaxel, Filgrastim, Gemcitabine

Completed
  • Recurrent Uterine Corpus Sarcoma
  • Uterine Corpus Leiomyosarcoma
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Dec 7, 2016

Collecting Tumor Samples From Patients With Gynecological Tumors

Completed
  • Borderline Ovarian Clear Cell Tumor
  • +85 more
  • Laboratory Biomarker Analysis
  • Fayetteville, Arkansas
  • +186 more
Oct 26, 2016